Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trialHiddo J.L. Heerspink, Toby Coates, Stewart Bieler et al.|The Lancet|2023Cited by 214
Increased Urinary Extracellular Vesicles and Reduced Expression of NEDD4L in Patients With Type 2 Diabetes and Diabetic NephropathyNikhil Thyagarajan, Jantina Manning|Journal of Diabetes Research|2026Cited by 0